Mexico authorized the emergency use of the vaccine Covaxin, manufactured in India, marking the sixth vaccine approved for use against COVID-19 in the country.
Foreign Minister Marcelo Ebrard made the announcement on his Twitter account, where he explained that the country now has AstraZeneca, Cansino, Covaxin, Pfizer, Sinovac and Sputnik V.
“Very timely decision by COFEPRIS to authorize the emergency use of the COVAXIN vaccine manufactured in India. The options for vaccination against COVID-19 in Mexico are expanding!!!,” Ebrard said on Twitter.
Covaxin is 81% effective
The vaccine developed by the . . .
